Loading...
HomeMy WebLinkAbout2020-06-24 - Agendas - ArchiveCouncil Member Sonia Gutierrez Ward 1 Position 1 Council Member Sarah Marsh Ward 1 Position 2 Council Member Mark Kinion Ward 2 Position 1 Council Member Matthew Petty Ward 2 Position 2 Mayor Lioneld Jordan City Attorney Kit Williams City Clerk Treasurer Kara Paxton City of Fayetteville Arkansas City Council Meeting June 24, 2020 Council Member Sloan Scroggin Ward 3 Position 1 Council Member Sarah Bunch Ward 3 Position 2 Council Member Teresa Turk Ward 4 Position 1 Council Member Kyle Smith Ward 4 Position 2 A Special meeting of the Fayetteville City Council was held on June 24, 2020 at 5:30 p.m. in Room 219 of the City Administration Building located at 113 West Mountain Street, Fayetteville, Arkansas. Call to Order Roll Call Pledge of Allegiance Mayor's Announcements, Proclamations and Recognitions: City Council Meeting Presentations, Reports, and Discussion Items: A. New Business 1. Establish the Fayetteville City Board of Health and the Position of City Health Officer: A resolution to establish the Fayetteville City Board of Health and the position of City Health Officer, and to approve a budget adjustment in the amount of $50,000.00. PASSED AND SHALL BE RECORDED AS RESOLUTION NO. 173-20 B. Announcements: C. Adjournment: 6:00 pm 113 West Mountain Fayetteville, AR 72701 (479) 575-8323 www.fayetteville-ar.gov City Council Meeting: June 24, 2020 AJJOW'(\ 6:00 Subject: Motion To: Motion By: ----� Seconded: Bunch Turk Smith f Gutierrez Marsh Kinion Petty Scroggin Mayor Jordan Subject: Motion To: Motion By: Seconded: Bunch Turk Smith Gutierrez Marsh Kinion Petty Scroggin Mayor Jordan WA OFFICE OF THE CITY ATTORNEY WEPARTMENTAL CORRESPONDENCE TO: Mayor Jordan Kit Williams City Attorney Blake Pennington Assistant City Attorney Jodi Batker THRU: Kara Paxton, City Clerk Paralegal FROM: Kit Williams, City Attorney DATE: June 25, 2020 RE: The Resolution prepared by the City Attorney's Office and passed at the Special City Council meeting of June 24, 2020 1. A RESOLUTION TO ESTABLISH THE FAYETTEVILLE CITY BOARD OF HEALTH AND THE POSITION OF CITY HEALTH OFFICER, AND TO APPROVE A BUDGET ADJUSTMENT IN THE AMOUNT OF $50,000.00 City of Fayetteville, Arkansas 113 West Mountain Street Fayetteville, AR 72701 (479) 575-8323 City Council Special Meeting Agenda Wednesday, June 24, 2020 5:30 PM City Hall Room 219 City Council Members Council Member Sonia Gutierrez Ward I Council Member Sarah Marsh Ward 1 Council Member Mark Kinion Ward 2 Council Member Matthew Petty Ward 2 Council Member Sloan Scroggin Ward 3 Council Member Sarah Bunch Ward 3 Council Member Teresa Turk Ward 4 Council Member Kyle Smith Ward 4 Mayor Lioneld Jordan City Attorney Kit Williams City Clerk Kara Paxton City Council Special Meeting Special Meeting Agenda June 24, 2020 Call To Order Roll Call Pledge of Allegiance Mayor's Announcements, Proclamations and Recognitions City Council Meeting Presentations, Reports and Discussion Items Agenda Additions A. New Business A. 1 2020-0526 ESTABLISH THE FAYETTEVILLE CITY BOARD OF HEALTH AND THE POSITION OF CITY HEALTH OFFICER: A RESOLUTION TO ESTABLISH THE FAYETTEVILLE CITY BOARD OF HEALTH AND THE POSITION OF CITY HEALTH OFFICER, AND TO APPROVE A BUDGET ADJUSTMENT IN THE AMOUNT OF $50,000.00 B. Announcements C. Adjournment NOTICE TO MEMBERS OF THE AUDIENCE City of Fayetteville, Arkansas Page 2 Printed on 612412020 City Council Special Meeting Special Meeting Agenda June 24, 2020 All interested persons may appear and address the City Council on Unfinished Business, New Business, and Public Hearings at City Council meetings. If you wish to address the City Council on an agenda item, please wait for the Mayor or Chair to request public comment then queue behind the podium. When the Mayor or Chair recognizes you, approach the podium and give your name and address. Comments are to be addressed to the Mayor or Chair. The Mayor or Chair will direct your comments to the appropriate elected officials, staff, or others for response. Keep your comments respectful, brief, to the point, and relevant to the agenda item being considered. Each speaker from the public will be allowed one turn at the microphone for discussion of an agenda item. Below is a portion of the Rules of Order and Procedure of the Fayetteville City Council pertaining to City Council meetings: Agenda Additions: A new item which is requested to be added to the agenda at a City Council meeting should only be considered if it requires immediate City Council consideration and if the normal agenda setting process is not practical. The City Council may only place such new item on the City Council meeting's agenda by suspending the rules by two-thirds vote. Such agenda addition shall be heard prior to the Consent Agenda. Consent Agenda: Consent Agenda items shall be read by the Mayor and voted upon as a group without discussion by the City Council. If an Alderman wishes to comment upon or discuss a Consent Agenda item, that item shall be removed and considered immediately after the Consent Agenda has been voted upon. Unfinished Business and New Business: Presentations by Staff and Applicants: Agenda items shall be introduced by the Mayor and, if an ordinance, read by the City Attorney. City staff shall then present a report. An agenda applicant (city contractor, rezoning or development applicant, etc.) may present its proposal only during this presentation period, but may be recalled by an alderman later to answer questions. City staff, City Council members, and applicants may use electronic visual aids in the City Council meeting as part of the presentation of the agenda item. Public Comments: Public comment shall be allowed for all members of the audience on all items of old and new business and subjects of public hearings. A simple majority of the City Council members, present and voting, may authorize a representative of a Fayetteville citizens' group opposing the ordinance or resolution to present an electronic visual aid not to exceed five minutes, but no other electronic visual aid presentations will be allowed; however, the public may submit photos, petitions, etc. to be distributed to the City Council. If a member of the public wishes for the City Clerk to distribute materials to the City Council before its meeting, such materials should be supplied to the City Clerk's Office no later than 9:00 A.M. on the day of the City Council meeting. Any member of the public shall first state his or her name and address, followed by a concise statement of the person's position on the question under discussion. Repetitive comments should be avoided; this applies to comments made previously either to the City Council or to the Planning Commission when those Planning Commission minutes have been provided to the City Council. All remarks shall be addressed to the Mayor or the City Council as a whole and not to any particular member of the City Council. No person other than the City Council member and the person having the floor shall be permitted to enter into any discussions without permission of the Mayor. No questions shall be directed to a City Council member or city staff City of Fayetteville, Arkansas Page 3 Printed on 612412020 City Council Special Meeting Special Meeting Agenda June 24, 2020 member except through the Mayor. Courtesy and Respect: All members of the public, all city staff and elected officials shall accord the utmost courtesy and respect to each other at all times. All shall refrain from rude or derogatory remarks, reflections as to integrity, abusive comments and statements about motives or personalities. Any member of the public who violates these standards shall be ruled out of order by the Mayor, must immediately cease speaking and shall leave the podium. Interpreters or Telecommunications Devise for the Deaf (TDD), for hearing impaired are available for all City Council meetings, a 72-hour advance notice is required. For further information or to request an interpreter, please call 479-575-8330. A copy of the complete City Council agenda is available on our website at www.fayetteville-ar.gov or in the office of the City Clerk, 113 W. Mountain, Fayetteville, Arkansas (479) 575-8323. All cell phones must be silenced and may not be used within the City Council Chambers. City of Fayetteville, Arkansas Page 4 Printed on 612412020 City of Fayetteville, Arkansas 113 West Mountain Street Fayetteville, AR 72701 (479)575-8323 Text File File Number: 2020-0526 Agenda Date: 6/24/2020 Version: 1 Status: Agenda Ready In Control: City Council Meetinq Agenda Number: A. 1 File Type: Resolution ESTABLISH THE FAYETTEVILLE CITY BOARD OF HEALTH AND THE POSITION OF CITY HEALTH OFFICER: A RESOLUTION TO ESTABLISH THE FAYETTEVILLE CITY BOARD OF HEALTH AND THE POSITION OF CITY HEALTH OFFICER, AND TO APPROVE A BUDGET ADJUSTMENT IN THE AMOUNT OF $50,000.00 WHEREAS, Ark. Code Ann. § 14-262-102 authorizes the City to establish a board of health and to "invest the board with such powers and impose upon it such duties as shall be necessary to ... secure the city and its inhabitants from the evils of contagious, malignant, and infectious diseases"; and WHEREAS, Ark. Code Ann. § 14-262-103 authorizes the City to create the position of City Health Officer with the powers and duties set forth in that statute; and WHEREAS, pursuant to Ark. Code Ann. § 14-262-116(b)(12) and § 14-262-115(a)(4), a city board of health is empowered "to adopt such rules and regulations, not inconsistent with the public health laws of this state nor with the orders and rules of the State Board of Health"; and WHEREAS, the significant rise in COVID-19 cases justifies the reinstitution of the City Board of Health and the re-establishment of the position of City Health Officer to assist the City with its response to the pandemic. NOW, THEREFORE, BE IT RESOLVED BY THE CITY COUNCIL OF THE CITY OF FAYETTEVILLE, ARKANSAS: Section 1: That the City Council of the City of Fayetteville, Arkansas hereby creates the City Board of Health which shall consist of five members appointed by the Mayor, at least two of whom shall be physicians of good professional standing. The initial members shall serve for the following terms: one shall serve for one (1) year, one for two (2) years, one for three (3) years, one for four (4) years, and one for five (5) years, from January 1 of the year appointed; thereafter, full -term appointments shall be for five (5) years. In addition to the Mayor and up to one city employee, the Mayor may appoint up to two ex-officio members who shall serve during the Mayor's term of office. The City Board of Health shall have those powers and duties conferred by Ark. Code Ann. § 14-262-102 including such powers as are necessary to secure the city and its inhabitants from the evils of contagious, malignant, and infectious diseases. The City Board of Health shall develop a job description for the City Health City of Fayetteville, Arkansas Page 1 Printed on 612412020 File Number: 2020-0526 Officer and submit nominations for that office to the Mayor when a vacancy occurs. The City Board of Health shall submit nominations for the ex-officio members to the Mayor at the beginning of the Mayor's term of office and shall include residents with expertise and credentials relevant to pressing public health issues affecting the jurisdiction of the City Board of Health. The City Board of Health shall promulgate rules and regulations necessary for the conduct of its meetings, including the election of officers, and for carrying out its statutory powers and duties, not inconsistent with the public health laws of this state nor with the orders and rules of the State Board of Health. Section 2: That the City Council of the City of Fayetteville, Arkansas hereby establishes the office of City Health Officer, who shall be a competent physician of reputable professional standing who is legally qualified to practice medicine in Arkansas. The City Health Officer shall be appointed by the Mayor and approved by the City Council. The City Health Officer shall have those powers and duties conferred by state law or city ordinance or resolution, but shall not be required to treat patients, prescribe medicine, or do anything else not statutorily required pursuant to Ark. Code Ann. § 14-262-103. Section 3: The City Council of the City of Fayetteville, Arkansas hereby determines that this Resolution should be reviewed within four weeks of the end of any relevant state of emergency to determine whether the City Board of Health should be dissolved, reconstituted, or repurposed. When such a state of emergency ends, the City Board of Health should provide a summary list, with annotations, of pressing public health issues. Section 4: That the City Council of the City of Fayetteville, Arkansas hereby approves a budget adjustment in the amount of $50,000.00 for staffing, supplies, and other needs of the City Health Officer and the City Board of Health in the course of their work. City of Fayetteville, Arkansas Page 2 Printed on 612412020 Legistar ID No.: 2020-0526 AGENDA REQUEST FORM FOR: Special City Council Meeting of June 24, 2020 FROM: Mayor Lioneld Jordan Council Member Matthew Petty ORDINANCE OR RESOLUTION TITLE AND SUBJECT: A RESOLUTION TO ESTABLISH THE FAYETTEVILLE CITY BOARD OF HEALTH AND THE POSITION OF CITY HEALTH OFFICER, AND TO APPROVE A BUDGET ADJUSTMENT IN THE AMOUNT OF $50,000.00 jo y=ioneld dan ate (ugoolad.) (al N /ZDLO Council Member Matthew Petty Date Assistant City Attorney Blake Pennington Date Approved as to form Pennington, Blake From: Matthew Petty - Fayetteville Ward 2 <citycouncil@matthewpetty.org> Sent: Wednesday, June 24, 2020 9:02 AM To: Pennington, Blake Cc: Mayor; Norton, Susan Subject: Re: Agenda Request Form CAUTION: This email originated from outside of the City of Fayetteville. Do not click links or open attachments unless you recognize the sender and know the content is safe. Confirmed. Thank you. I will transmit final materials for the packet within the hour On Wed, Jun 24, 2020, 8:32 AM Pennington, Blake <bpennington@favetteville-ar.gov> wrote: I have heard there will be a special city council meeting this evening to discuss the board of health resolution. I am attaching a revised agenda request form to reflect the date change. Matthew, if you will confirm you are requesting this item be added to the agenda for the special meeting today that will be sufficient. Blake Blake E. Pennington Assistant City Attorney 113 W. Mountain St., Suite 302 Fayetteville, Arkansas 72701 Telephone: (479) 575-8313 bpennington@fayetteville-ar.gov<mailto:bpennington@fayetteville-ar.gov> [City attorney logo]<http://www.fayetteviIIe-ar.gov/492/City-Attorney>[cid:image002.jpg@01D287AB.2928C1EO] <http://www.fayetteville-ar.gov/> Facebook<https://www.facebook.com/fayettevillearkansasgovernment> I Twitter<https://twitter.com/fyvgov> Instagram<https://www.instagram.com/fyvgov/> I YouTube<http://www.youtube.com/user/cityoffayettevillear> CITY OF Fay t-11e AANSAS TO: City Council Mayor FROM: Matthew Petty, Councilmember Susan Norton, Chief of Staff DATE: June 23, 2020 SUBJECT: A resolution to reconstitute a Fayetteville Board of Health MEMO Background In Arkansas, cities can create a Board of Health. State law § 14-262-102 and other related statutes give a Board of Health important powers during epidemics. The City of Fayetteville repealed its Board of Health less than two years ago due to lack of business. The proposal is to reconstitute the Board as an independent body whose purpose is primarily advisory with respect to relevant governmental units (see Duties in the included prospective agenda). Other duties may be taken up by the Board if the Board judges those duties to be necessary for the public health and in accordance with relevant ordinances, statutes, and guidelines. Timeline First meeting: As soon as possible, subject to Board availability. Subsequent meetings: Loosely speaking, every two weeks during an epidemic. City Health Officer State law also provides for cities to appoint a City Health Officer with certain duties. The proposal is for the position to be created and funded by the city in coordination with the new Board's advice. Funding Another component of the proposal is a budget adjustment of $50,000 in emergency funding to support the Board and City Health Officer in the execution of their duties. Positions State statute sets the formal membership of the Board at five members, two of whom must be physicians. This proposal is to extend that membership with ex-officio positions as may be judged necessary by the Mayor and as advised by the Board of Health. Ex-officio positions are intended to be occupied by qualified individuals with credentials relevant to pressing public health conditions. The proposal recommends filling the new Board with the following positions: 1. Officer or director of city's largest medical research institution 2. Officer or director city's largest hospital system Mailing Address: 113 W. Mountain Street www.fayetteville-ar.gov Fayetteville, AR 72701 3. Current or former university clinic director/manager 4. Current or former multi -site clinic director/manager 5. Current or former director/manager of a psychiatric clinic or social services provider • Ex-officio, at -large with relevant credentials • Ex-officio, at -large with relevant credentials • Ex-officio, city public safety director as designated by the Mayor • Ex-officio, Mayor Prospective members 1. Jay Gandy, PhD. Associate Provost, UAMS Northwest. 2. Lenny Whiteman. Vice President of Managed Care, Washington Regional. 3. Huda Sharaf, MD. Medical Director, Pat Walker Health Center. 4. Gary Berner, MD. Chief Medical Officer, Community Clinic. 5. Joey Gardner, DSW. Care Coordinator Supervisor, Beacon Health Operations. • Stephanie Ho, MD. Physician, Vector Health and Wellness. • Hershey Garner, JD MD. Physician, Highlands Oncology Group. • Brad Hardin. Fire Chief, City of Fayetteville. • Lioneld Jordan. Mayor, City of Fayetteville. Prospective First Agenda The proposal also suggests a first agenda for the new Board. While the Board is independent and will set its own agenda, this agenda is presented as a guide for the new Board to use in their first meeting. Election of a chairperson and summary bylaws The Chairperson shall preside over the meetings and serve as the primary point of contact with the City and/or a City Health Officer. 1. Chair calls meetings and presides over them. 2. Chair sets meeting agendas. 3. Chair executes Board decisions; city assists and collaborates. 4. Rules and roles may change when a City Health Officer is appointed. Summary jurisdiction and powers Board has jurisdiction for one mile beyond the city limits, or five miles beyond the city limits during an epidemic, by state statute. The Board has the power to assess and advise, and to issue from time to time such orders and to adopt such rules and regulations, not inconsistent with the public health laws of this state nor with the orders and rules of the State Board of Health, as the Board may deem necessary for the proper exercise of its powers and duties. Refer to the enabling statute for a full description of the jurisdiction and powers. Summary purpose The intended purpose is to advise relevant governmental units of the state of health of the population within the statutory jurisdiction of the Board, including with respect to declared public health emergencies. The Fayetteville City Council has directed the Board to focus on the COVID-19 infectious disease epidemic. Refer to enabling statutes for a complete description of the purpose. Sunset The City Council is required to consider the Board's dissolution, reconstitution, and/or repurposing within four weeks of the end of any relevant state of emergency. When such a state of emergency ends, the Board should provide a summary list, with annotations, of pressing public health issues. Duties Advise relevant governmental units as to the following: a. Public health threats, including infectious disease epidemics, and opportunities for coordinated mitigation b. Strategies, metrics, and benchmarks with respect to governmental public health campaigns, specifically with respect to i. Increasing adoption of advised personal health practices in the household and the workplace ii. Increasing voluntary compliance with public health advisories iii. Increasing understanding of public health best practices and policies 1. Specifically including but not limited to, increasing voluntary compliance of mask -wearing advisories 2. Make reports of the Board's meetings available to relevant governmental units. Independence of the Board 1. The Board sets its own agendas. 2. The Board is intended to be an agent for the public health itself and not be beholden to any particular political interest. 3. All advice provided by the Board should be based on empirical evidence to the greatest extent possible. Vote: Resolution affirming the City of Fayetteville is in a state of epidemic Sample resolution text, to be amended at the Board's discretion: On the basis of the best epidemiological reporting and analysis available to the Fayetteville Board of Health and in accordance with all relevant ordinances and statutes, the Board hereby affirms there is an infectious disease epidemic within its jurisdiction. City report on communication with state officials The City will provide a short briefing (ten minutes). Vote: Resolution advising the epidemiological necessity of Fayetteville's mask law Sample resolution text, to be amended at the Board's discretion: On the basis of the best epidemiological reporting and analysis available to the Fayetteville Board of Health, the Board hereby advises Ordinance 6323, colloquially known as the Fayetteville Mask Ordinance and which establishes a mask requirement, reasonable exemptions, and a public health campaign, is necessary to meet the community's COVID-19 management targets and protect the health, safety, and welfare of its inhabitants. Feedback on city report on public outreach and education The city will provide a short briefing (ten minutes) to the Board on efforts to promote mask - wearing and other practices which reduce the spread of COVID-19. The Board is asked to provide feedback to the City to maximize the impact of the City's resources. The City has currently budgeted $100,000 for this effort. Vote: Resolution requesting state COVID-19 press conference in Fayetteville Sample resolution text, to be amended at the Board's discretion: In consideration of the state of epidemic in the City of Fayetteville and Governor Asa Hutchinson's call for a coordinated response with local cities, the Fayetteville Board of Health respectfully requests the daily Arkansas COVID-19 press conference be held in Fayetteville in approximately two weeks and that attending state officials meet with relevant institutions and leaders at that time. Preliminary discussion of City Health Officer position The Board is requested to provide a shortlist to the Mayor to fill this position. The City will provide a short briefing (five minutes) to the Board about the role of this position with respect to the municipal apparatus. The Board is invited to discuss the potential of this position and to assist with the creation of a job description, including how an interim function may be served by a Board member, city staff, or other qualified individual. City funding has been made available to meet these needs. Set next meeting Adjourn 11 CURRICULUM VITAE Jay Gandy, Ph.D. Associate Provost University of Arkansas for Medical Sciences, Northwest 1125 N. College Ave. Work phone: 479-713-8125 Fayetteville, AR 72703 e-mail: jgandy(@uams.edu Date of Birth: January 15, 1954 Place of Birth: Memphis, TN EDUCATION: Ph.D. 1985 University of California, Riverside (Field of Study - Toxicology) M.S. 1982 University of California, Davis (Field of Study - Neurotoxicology) B.S.A. 1976 University of Arkansas - (Entomology - with High Honors) EMPLOYMENT: 2019-present Associate Provost University of Arkansas for Medical Sciences, Northwest Arkansas Campus 2019 Interim Dean Fay W. Boozman College of Public Health University of Arkansas for Medical Sciences (UAMS) 2001-present Professor Dept. of Environmental and Occupational Health Fay W. Boozman College of Public Health University of Arkansas for Medical Sciences 2001 -April 2020 Chair Dept. of Environmental and Occupational Health Fay W. Boozman College of Public Health University of Arkansas for Medical Sciences 1997-2010 Principal Toxicologist and Founding Partner Center for Toxicology & Environmental Health, L.L.C. 2010-Present Director, Regulatory Sciences Program, UAMS Graduate School 1996-2012 Director, Occupational & Environmental Health M.S. Program UAMS Graduate School 1991-2007 Associate Professor Dept. of Pharmacology & Toxicology, College of Medicine UAMS 1992 AAAS/EPA Environmental Fellow Office of Research and Development 06/22/20 1991 1986-1991 1985-1986 U.S. Environmental Protection Agency Washington, D.C. Visiting Associate Professor Division of Medical Toxicology, College of Medicine Univ. of Colorado Health Sciences Center Assistant Professor Dept. of Pharmacology & UAMS Instructor in Toxicology Dept of Pharmacology & UAMS PROFESSIONAL SOCIETIES: Toxicology, College of Medicine Toxicology, College of Medicine Society of Toxicology South Central Chapter Society of Toxicology American Chemical Society American Conference of Governmental Industrial Hygienists Delta Omega (Honary Society in Public Health) EDITORIAL BOARDS OF PEER REVIEWED JOURNALS: Toxicological Sciences (1999-2002) Toxicology Letters (1996-2000) Fundamental and Applied Toxicology (1995-1998) GRANTS AND CONTRACTS: NIH: NIOSH. Epididymal GSH in chemical -induced germ cell mutations. Award period: May 1986-April 1988. Role: Principal Investigator. NIH: National Institute of Occupational Safety and Health. Epididymal GSH in chemical -induced germ cell mutations. Award period: May 1986-April 1988; Role: Principal Investigator NIH: National Institute of Environmental Health Sciences. Role of glutathione in male reproductive toxicity. Award period: July 1989-June 1994; Role: Principal Investigator NIH: National Institute of Environmental Health Sciences. Immunotoxicity of propanil and tetrachloroazobenzene. Award Period: January 1989-December 1994; Role: Co -Investigator 06/22/20 American Institute for Cancer Research. Effects of caloric restriction on rat testicular tumor formation. Award Period: January 1993-December 1994; Role: Principal Investigator U.S. Environmental Protection Agency. Arkansas Clinical and Developmental Toxicology Program. Award period (Tom Badger, PI): July 1994-June 1996; Role: Program Manager Program Project: Evaluation of the immunotoxic properties of the herbicide, propanil, in families. Role: Principal Investigator Program Project: Establishment of a Toxicant Exposure Registry in Arkansas. Role: Principal Investigator U.S. Environmental Protection Agency. Improved reproductive risk assessment by elucidation of metabolic functions. January 2000-December 2001. Role: Principal Investigator NIH: National Institute of Child Health and Human Development. National Children's Study — Arkansas Study Center (Charolett Hobbs, PI), October 2008- October 2011. Role: Co -Investigator U.S. Environmental Protection Agency. Integrated Science Assessment for Lead Toxicity: Evidence of Reproductive and Developmental Effects of Lead. Contract Period: August 2010-June 2011. Role: Document Author. U.S. Environmental Protection Agency Human Health Risk Assessment. Integrated Science Assessment for Particulate Matter. Contract Period: May 2015-April 2016. Role: Section Author. GOVERNMENTAL ADVISORY POSITIONS: Pesticide toxicology consultant for EPA Technical Assistance Team at the Minot, ND pesticide warehouse fire. 1987. Arkansas Department of Health - Environmental Health Conferences: Exposure to Hazardous Substances in Arkansas. Presentations to Arkansas physicians at AHEC Centers on health effects of pesticide exposures. 1989-1991 U.S. Food and Drug Administration - Lecturer on chemical classes and toxicities of pesticides for FDA state health departments training courses entitled "Pesticides and Industrial Chemicals" - Training course presented in Little Rock, AR, Seattle, WA, Princeton, NJ, Minneapolis, MN and Denver, CO. 1990-1992 U.S. Food and Drug Administration - Lecturer on the interactions of science and law for FDA state health departments training courses entitled, "Legal Aspects of Enforcement"; presented in Harrisburg, PA. Weston, W. VA, Little Rock, AR, Phoenix, AZ, Louisville, KY, and Jackson, MS. 1987-1990 Consideration of different risk assessment approaches for male reproductive toxicities. Prepared for the U.S. Environmental Protection Agency, 1992. Consultation to the Arkansas Dept. of Health and the Ark. State Plant Board regarding health effects of Command herbicide drift, 1993. 06/22/20 Testimony before the Arkansas General Assembly Joint Committee on Public Health, Welfare & Labor - Investigation of health risks related to Command herbicide, 1993. Consultation to the Arkansas Dept. of Health and the Ark. State Plant Board regarding health effects of herbicide groundwater contamination, 1994. U.S. Environmental Protection Agency Fellowship Grant Review Panel, 1995. NIH National Center for Research Resources Site -visit Review Committee, 1995. U.S. Environmental Protection Agency Fellowship Grant Review Panel, 1996. NIH National Center for Research Resources Initial Review Group, 1996. National Center for Toxicological Research, Toxicology Study Section and Review Committee (Endocrine disruptors), U.S. Food & Drug Administration, 1996- 1998. U.S. Environmental Protection Agency Fellowship Grant Review Panel, 1997. U.S. Environmental Protection Agency's Health -Related Life Sciences Peer Review Panel, 1997. NIH National Toxicology Program External Scientific Reviewer, 1997-2000. Consultation to the Arkansas Dept. of Health regarding potential health effects associated with trace dioxin levels in chicken, eggs, and catfish, 1997. U.S. Environmental Protection Agency — Animal Testing External Peer Reviewer, 1997. U.S. Environmental Protection Agency — Peer review of reference dose (RfD) determination for reproductive studies of chlorite, 1998. Arkansas Department of Health Expert Panel Selection and Planning Committee, 1998. Contractor to Arkansas Department of Health - provide technical assistance in the performance of a cooperative agreement with the Department of Army regarding activities related to Chemical Demilitarization Project at the Pine Bluff Arsenal, 1997-98. U.S. Environmental Protection Agency Grant Peer Review Panel — Interindividual variation in human susceptibility to environmentally -caused disease, 1998. U.S. Environmental Protection Agency Reference Dose Peer Review Panel — IRIS Toxicological Review for Vinyl Chloride. 1999. Peer reviewer for DOD/VA Health Research Program, US Army Medical Research and Material Command, 1999. 4 06/22/20 Grant reviewer for NIOSH Southwest Center for Occupational and Environmental Health, Univ. of Texas, 2000. Interagency Coordinating Committee on the Validation of Alternative Methods/ National Toxicology Program - Expert Panel to assess validation status and usefulness of FETAX assay for regulatory purposes, 2000. CDC National Institute for Occupational Safety and Health Special Emphasis RFA Peer Review Panel, 2000. Arkansas Department of Health Search Committee for Director of Epidemilogy, 2000-01. Arkansas Department of Health: Consultant to Public Health Laboratory Biomonitoring Planning Grant, 2001-2003. U.S. Environmental Protection Agency External Peer Review of oral two -generation reproduction study of dibromoactic acid, 2002. Assocition of Schools of Public Health/CDC Global Health Fellowship Reviewer, 2008 EPA/ASPH Environmental Health Fellowship Program Reviewer, 2009. U.S. EPA Integrated Science Assessment for Lead, Consultant/Section Author for Toxicological Evidence of Reproductive and Developmental Effects of Lead Section, 2011. U.S. EPA Draft Drinking Water Health Advisory for 1,3-dichloropropene and Summary from the Advisory for 1,3-Dichloropropene, External Peer Reviewer, 2012. Science Advisory Board, National Center for Toxicological Research, U.S. Food and Drug Administration. 2012-2016. Science Advisory Board Subcommittee Review of FDA NCTR Division of Microbiology, Committee Co -Chair. July 2013. Science Advisory Board Subcommittee External Review of FDA NCTR Division of Biochemical Toxicology, Committee Co -Chair. November 2014. U.S. EPA Integrated Science Assessment for Particulate Matter, Consultant/Section Author for Toxicological Evidence of Reproductive and Developmental Effects, 2015-2016. U.S. EPA External Peer Review of the Draft Provisional Peer -Reviewed Toxicity Value (PPRTV) document for 1,1,2-Trichloro-1,2,2-Trifluoroethane, 2016 Arkansas Reproductive Health Comitoring System Advisory Commission, 2016- 2018. U.S. EPA External Letter Peer Review of a Study Report on 1,3,5-trinitro-1,3,5- hexahydrotriazine (RDX) Performed by Midwest Research Institute (Cholakis et al., 1980). 2017. 06/22/20 U.S. EPA External Peer Review of Two Laboratory Reports on Chloroform in Wistar Rats Performed by Hoechst Aktiengesellschaft, 2018. PROFESSIONAL SERVICE: Councilor (Immediate -Past President) - South Central Chapter of the Society of Toxicology, 1997-98 President - South Central Chapter of the Society of Toxicology, 1996-97 President -Elect - South Central Chapter of the Society of Toxicology, 1995-96 Vice -President - South Central Chapter of the Society of Toxicology, 1994-95 Counselor - South Central Chapter of the Society of Toxicology, 1992-94 SIGNIFICANT UNIVERSITY SERVICE AND COMMITTEES Institutional Animal Care and Use Committee. 1985-1987 LCME Accreditation Self -study Subcommittee for Department of Biochemistry evaluation. 1991 Chair, Biomedical Research Center Facilities Management Committee. 1994-96 Graduate Council, Interdisciplinary Toxicology Representative. 1994-1998 Graduate Council Subcommittee on Faculty Graduate Council, Occupational & Environmental Health Representative. 1998- 2002 Graduate Council Subcommittee on Faculty Institutional Copyright Guidelines Committee (College of Medicine representative). 1998-2000 College of Public Health Planning Committee, (COPH) Curriculum Subcommittee. 2000-2001 Search Committee for Dean, College of Public Health. 2002 COPH Dean's Executive Committee, 2004-present COPH Appointment, Promotion, and Tenure Committee. 2003-2006; 2019-present COPH Appointment, Promotion, and Tenure Committee, Chair - 2006-2018 COPH Faculty Incentive Plan Committee. 2010 BioVentures Business Accelerator Advisory Board. 2009-2016 Program Director— Regulatory Sciences Program 2011-present Search Committee Chair: Department of Health Policy and Management Chair — 2013 Working Group on Facutly Performance Excellence, 2014 Search Committee Chair: Department of Epidemiology Chair — 2015 UAMS Patent and Copyright Committee, 2017-present Search Committee Chair: Dean, College of Public Health 2018-2019 Search Committee Chair: Vice Chancellor for Human Relations, 2019 Search Committee Chair: Associate Provost for Faculty & Continuing Education, 2020 UAMS laison to UAF-UAMS Research Collaborative, 2000: Pilot Study Funding Committee Chair; Intercampus Transportation Committee Chair; Smooth Funding Intrastructure Subcommittee Co-chair; Logistics, Policy and Process Subcommittee Co-chair. UAMS-UAF Joint MD/MBA Program Committee, 2020 06/22/20 TEACHING EXPERIENCE: Toxicology for Graduate Students (Pulmonary tox. & Repro. tox. lectures) 1986-2004 General Principles of Pharmacology and Toxicology (Drug metabolism & Risk assess. lectures) 1992-2007 Advanced Toxicology (Pesticides, silicones, asbestos, silica, phthalates, risk assessment lectures) 1987-2005; Course director 1989-2000 Government Regulations in Toxicology, (Course Director 1985-2005) Emergency Medicine Residency Program - Pesticide toxicities, 1990 Medical Pharmacology (General principles of toxicology and pesticide lectures to medical students) 1994-2002, 2006. Co -leader small group case conferences 1994-1996 Community Health Nursing (Toxicology & Environmental Health lectures) 1994-2016 UALR Law School, Environmental Law (Principles of toxicology and risk assessment lecture) 1994 Family and Community Health Practice Residency Program - General Priniples of Toxicology and Causation Analysis, 1996 Government Regulations in Public Health 2009-2011, 2013-present Clinical Toxicology (Dept. Pharmacology & Toxicology: Pesticide lecture) 2009-2015 Introduction to Public Health (Intro to Environmental & Occ. Health lecture) 2005- 2010 Environmental Health Policy 2010-2012 Principles of Food and Drug Regulations 2012 - 2018 PUBLICATIONS: Imamura, T., J. Gandy, T.R. Fukuto and P. Talbot. 1983. An impurity of malathion alters the morphology of rat lung bronchiolar epithelium. Toxicology 26:73-79. 2. Imamura, T., L. Hasegawa, J. Gandy and T.R. Fukuto. 1983. Effect of drug metabolism inducer and inhibitor on O,O,S-trimethyl phosphorothioate-induced delayed toxicity in rats. Chemico.-Biol. Interact., 45:53-64. 3. Imamura, T., J. Gandy and T.R. Fukuto. 1983. Selective inhibition of rat pulmonary monooxygenase by O,O,S-trimethyl phosphorothioate treatment. Biochem. Pharmacol. 32:3191-3195. 4. Gandy, J., P. Talbot, T.R. Fukuto and T. Imamura. 1983. Phenobarbital pretreament protects against morphological changes in rat bronchiolar epithelium caused by an impurity of malathion. Amer. J. Pathol. 111:350-353. 5. Gandy, J., T.R. Fukuto and T. Imamura. 1984. Sequential and dose -dependent morphological alterations in the rat bronchiolar epithelium during O,O,S-trimethyl phosphorothioate induced delayed toxicity. J. Pathol. 143:127-137. 6. Gandy, J., F.A.F. Ali, L. Hasegawa and T. Imamura. 1984. Morphological alteration of rat lung bronchiolar epithelium produced by various trialkyl phosphorothioates. Toxicology 32:37-46. 7. Imamura, T., J. Gandy and L, Hasegawa. 1985. Development of tolerance to a pneumotoxic impurity of malathion. J. Toxicol. Environ. Health., 15:279-291. 06/22/20 8. Gandy, J. and T. Imamura. 1985. Cellular responses to O,O,S-trimethyl phosphorothioate-induced pulmonary injury in rats. Toxicol. Appl. Pharmacol., 80:51-57 9. Gandy, J., C.M. Teaf, F.A. Adatsi, R.C. James and R.D. Harbison. 1987. The dependence of male reproductive toxicity on germ cell stage. In: Functional Teratogenesis: Functional Effects on the Offspring After Parental Drug Exposure, T. Fuji and P.M. Adams (Eds.), Teikyo University Press, Tokyo, Japan, pg 133-143. 10. Gandy, J. and T. Imamura. 1987. A phosphorothionate isomer protects against the pneumotoxicity caused by O,O,S-trimethyl phosphorothioate. Toxicol. Appl. Pharmacol. 87:498-508. 11. Kerger, B.D., J. Gandy, T.J. Bucci, S.M. Roberts, R.D. Harbison and R.C. James. 1988. Antagonism of bromobenzene-induced hepatotoxicity by the alpha adrenergic blocking agents, phentolamine and idazoxan. Toxicol. Appl. Pharmacol., 95:12-23. 12. Imamura, T. and J. Gandy. 1988. Pulmonary toxicity of phosphorothioate impurities found in organophosphate insecticides. Pharmacol. Ther., 38:419-427. 13. Kerger, B.D., S.M. Roberts, J.A. Hinson, J. Gandy, R.D. Harbison and R.C. James. 1988. Antagonism of bromobenzene-induced hepatotoxicity by phentolamine: evidence for a metabolism independent intervention. Toxicol. Appl. Pharmacol., 95:24-31. 14. Durham, S.K., J. Gandy and T. Imamura. 1988. Atrophine pretreatment does not abrogate O,O,S-trimethyl phosphorothiate-induced bronchiolar injury in mice. Toxicol. Pathology, 16:392-395. 15. Harbison, R.D., C.C. Conaway, L.F. Rubin and J. Gandy. 1989. A study of chronic morpholine exposure in rats. Fund. Appl. Toxicol., 12:491-507. 16. Barnett, J. B. and J. Gandy. 1989. Effect of acute exposure on the immune response of C57131/6 mice. Fund. Appl. Toxicol., 12:757-764. 17. Stidman, J., E.H. Taylor, H.F. Simmons, J.Gandy, and A.A. Pappas. 1989. Determination of meprobamate in serum by alkaline hydrolysis, trimethylsilyl derivatization and detection by gas chromatography -mass spectrometry. J. Chromatogr., 494: 318-323. 18. Mattison, D.R., D.R. Plowchalk, M.J. Meadows, A.Z. AI-Jubure, J. Gandy and A. Malek. 1990. Reproductive toxicity: the male and female reproductive systems as targets for chemical injury. Med. Clinics N. Am., 74:391-411. 19. Gandy, J., G.C. Millner, H.K. Bates, D.A. Casciano, and R.D. Harbison. 1990. The effects of selected chemicals on the glutathione status of the male reproductive system of rats. J. Toxicol. Eviron. Health, 29:45-57. 20. Barnett, J.B., B.L. Blaylock, J. Gandy, J.H. Menna, R. Denton and L.S.F. Soderberg. 1990. Long-term alteration of adult bone marrow colony -formation by prenatal chlordane exposure. Fund. Appl. Toxicol., 14:688-695. 06/22/20 21. Barnett, J.B., B.L. Blaylock, J. Gandy, J.H. Menna, R. Denton and L.S.F. Soderberg. 1990. Alteration of fetal liver colony formation by prenatal chlordane exposure. Fund. Appl. Toxicol., 15:820-822. 22. Blaylock, B.L., L.S.F. Soderberg, J. Gandy, J.H. Menna, R. Denton, and J.B.Barnett. 1990. Cytotoxic T Lymphocyte and NK responses in mice treated prenatally with chlordane. Toxicol. Lett., 51:41-49. 23. Seng, J.E., J.E. Leakey, M.P. Arlotto, A. Parkinson and J. Gandy. 1991. Cellular localization of cytochrome P450IIAl in testes of mature Sprague-Dawley rats. Biol. Reproduction, 45:867-882. 24. Barnett, J.B., J. Gandy, D. Wilbourn and S.A. Theus. 1992. Comparison of the immunotoxicity of propanil and its metabolite, 3,4-dichloroaniline, in C57131/6 mice. Fund. Appl. Toxicol., 18:628-631. 25. Gandy, J., H.K. Bates, L.A. Conder and R.D. Harbison. 1992. Effects of reproductive tract glutathione enhancement and depletion on ethyl methanesulfonate-induced dominant lethal mutations in Sprague-Dawley rats. Teratogen. Carcinogen. Mutagen. 12:61-70. 26. Theus, S.A., D.R. Tabor, J. Gandy, and J.B. Barnett. 1993. Alteration of macrophage cytotoxicity through endogenous interferon and tumor necrosis factor- induction by propanil. Toxicol. Appl. Pharmacol. 118:46-52. 27. Gandy, J., S.K. Durham and T. Imamura. 1993. Pulmonary toxicity induced by phosphorothioate impurities present in organophosphate insecticides. In: International Encyclopedia of Pharmacology and Therapeutics: Metabolic Activation and Toxicity of Chemical Agents to Lung Tissue and Cells. T.E. Gram, Ed., Pergamon Press, Oxford, p 153-163. 28. Primiano, T., J. Gandy, J.L. York and R.F. Novak. 1993. Enhanced glutathione S- transferase 7-7 expression in rat hepatic cytosol following treatment with pyrrole. Biochem. Biophys. Res. Comm. 190:1136-1142. 29. Evenson, D.P., L.K. Jost and J. Gandy. 1993. Glutatione depletion potentiates ethyl methansulfonate-induced damage to sperm chromatin structure.. Repro. Toxicol. 7:297-304. 30. Blyler, G., K.S. Landreth, T. Lillis, R. Schafer, S.A. Theus, J. Gandy, and J.B. Barnett. 1994. Selective myelotoxicity of propanil. Fund. Appl. Toxicol. 22:505-510. 31. Zhao, W., R. Schafer, C.F. Cuff, J. Gandy, and J.B. Barnett. 1995. Changes in primary and secondary lymphoid organ T cell subpopulations resulting from acute in vivo exposure to propanil. J. Toxicol. Environ. Health 46:101-111. 32. Gandy, J., T. Primiano, R.F. Novak, W.R. Kelce, and J.L. York. 1996. Differential expression of glutathione s-transferase isoforms in compartments of the testis and segments of the epididymis of the rat. Drug Metabol. Disposition 24:725-733. 33. Seng, J.E., J. Gandy, A. Turturro, R. Lipman, R.T. Bronson, W. Johnson, R.W. Hart, and J.E. Leakey. 1996. Effects of caloric restriction on expression of testicular 06/22/20 cytochrome P450 enzymes associated with the metabolic activation of carcinogens. Arch. Biochem. Biophy. 335:42-52. 34. Ronis, M.J.J., L.M. Bell, J. Parker, M. Shaw, J. Gandy, T.M Badger, and K. Green. 1996. Neuroendocrine mechanisms underlying the reproductive toxicity of lead in a rat lifetime exposure model. In: Metal Ions in Biology and Medicine, 4: 420-422. P. Collery, J.L. Domingo, J.C. Etienne, J.M. Liobet (Eds.). John Libbey Eurotext, Paris. 35. Ronis, M.J.J., J. Gandy, and T. Badger. 1998. Endocrine mechanisms underlying the reproductive effects of developmental lead exposure in the rat. J. Toxicol. Environ. Health 54:77-99. 36. Nye, A.C., G.C. Millner, J. Gandy, and P.T. Goad. Examples of risk assessment applications. In: Williams, P. L, James, R. C., and Roberts, S. M., Editors. Principles of Toxicology: Environmental and Industrial Applications. 2nd ed. New York: John Wiley & Sons, Inc.; 2000; pp. 479-498. 37. Chang, H.C., J.E. Seng, J.E.A. Leakey and J. Gandy. 2000. Metabolism of flutamide in diet control rats, and its hydroxylation and conjugation by human CYP450s and UGT-glucuronosyltranferases. J Food Drug Anal. 8(3): 166-173. 38. Richards, S. M., G.Y. McClure, T.L. Lavy, J.D. Mattice, R.J. Keller, and J. Gandy. 2001. Propanil (3,4-dichloropropionanilide) particulate concentrations within and near the residences of families living adjacent to aerially sprayed rice fields. Archives Environ. Contam. Toxicol. 41:112-116. 39. McClure, G.Y.H., R.M. Helm, K. Stine, A.W. Burks, S.M. Jones and J. Gandy. 2001. Evaluation of immune parameters in propanil exposed farm families. Archives Environ. Contam. Toxicol. 41:104-111. 40. Jones, S.M., A.W. Burks, H.J. Spencer, S. Lensing, P.K. Roberson, J. Gandy, and R.M. Helm. 2003. Occupational asthma symptoms and respiratory function among aerial pesticide applicators. Am. J. Indust. Medicine 43:407-417. 41. Golden, R., J. Gandy, and G. Vollmer. 2005. A review of endocrine activity of parabens and implications for potential risks to human health. Crit. Rev. Toxcol. 35:435-458. 42. Thomas, N.I., N.D. Brown, L.C. Hodges, J. Gandy, L. Lawson, J.E. Lord, D.K. Williams. 2006. Factors associated with work -related injury among hospital employees. AAOHN J. 54: 24-31. 43. Thomas, N.I., N.D. Brown, L.C. Hodges, J. Gandy, L. Lawson, J.E. Lord, D.K. Williams. 2006. Risk profiles for four types of work -related injury among hospital employees: a case -control study. AAOHN J. 54: 61-68. 44. Ansari, R.A., and J. Gandy. 2007. Determining the transrepression activity of xenoestrogen on NF-KB in Cos-1 cell by estrogen receptor -a (ER -a). Int. J. Toxicol. 26(5):441-9. 45. Hewitt, D.J. and J. Gandy. 2009. Characterization of a fatal methyl bromide exposure by analysis of trapped air in the headspace of a water cooler. Am. J. Indust. Medicine 52(7):579-86. 10 06/22/20 Dr. Gandy Curriculm vitae ABSTRACTS: 1. Imamura, T., J. Gandy and T.R. Fulkuto. 1983. Selective inhibition of rat pulmonary microsomal enzymes by O,O,S-trimethyl phosphorothioate treatment. The Toxicologist 3:42. 2. Gandy, J., T.R. Fukuto and T. Imamura. 1983. Sequential and dose -dependent morphological alterations in the rat bronchiolar epithelium during O,O,S-trimethyl phosphorothioate induced delayed toxicity. The Toxicologist 3:43. 3. Gandy, J., T.R. Fukuto and T. Imamura. 1983. Relationship of delayed death and alteration of rat lung bronchiolar epithelium caused by trial kylphosphorothioate structural analogues. Toxicol. Lett. 18:73. 4. Imamura, T., A. J. Gray, J. Gandy and T. R. Fukuto. 1983. Protective effects of mixed -function oxidase inducers and inhibitors against O,O,S-trimethyl phosphorothioate induced toxicity in rats. Toxicol. Lett. 18:73. 5. Imamura, T., J. Gandy and L. Hasegawa. 1984. Development of tolerance to a pneumotoxic impurity of malathon. Fed. Proc. 43:761. 6. Gandy, J. and T. Imamura. 1984. The pneumotoxic effects of an impurity of organophosphorus insecticides. Neurotoxicology 5:76. 7. Gandy, J. and T. Imamura. 1985. A phosphorothionate isomer protects against the pneumotoxicity caused by O,O,S-trimethyl phosphorothioate, The Toxicologist 5:69. 8. Gandy, J. and T. Imamura. 1985. Kinetic response of alveolar and bronchiolar cells to O,O,S-trimethyl phosphorothioate-induced pulmonary injury in rats. Fed. Proc. 44:719. 9. Millner, G.C., J. Gandy, D. Casciano and R.D. Harbison. 1986. The effect of selected chemicals on glutathione (GSH) levels in the male reproductive tract. The Toxicologist 6:290. 10. Kerger, B.d., R.D. Harbison, T.J. Bucci, R.C. James and J. Gandy. 1986. Antagonism of bromobenzene-induced hepatotoxicity by the adrenergic blocking agent, phentolamine. The Pharmacologist 28(3):180. 11. Harbison, R.D., J. Gandy and R.C. James. 1986. Confounding factors in risk assessment. Annual Meeting of the American Society of Animal Science. 12. Gandy, J., C.M. Teaf, F.A. Adatsi and R.D. Harbison. 1986. The dependence of male reproductive toxicity on germ cell stage. Satellite Symposium of the Fourth International Congress of Toxicology, Tokyo, Japan, July, 1986. 13. Barnett, J.B., L. Buehler and J. Gandy. 1987. Immunotoxic effects of propanil in mice. Fed. Proc. 46:539. 11 06/22/20 Dr. Gandy Curriculm vitae 14. Kerger, B.D., J.A. Hinson, R.D. Harbison, S.M. Roberts, J. Gandy and R.C. James. 1987. Antagonism of bromobenzene-induced hepatotoxicity: Evidence for a pharmacological intervention by phentolamine. The Pharmacologist 29(3):148. 15. Gandy, J., L.A. Buehler and R.D. Harbison. 1987. The role of reproductive tract glutathione in protecting against sperm head alkylations. The Pharmacologist 29(3):221. 16. Bates, H.K., R.D. Harbison and J. Gandy. 1988. Circadian fluctuation of glutathione levels in the reproductive tract of the male rat. The Toxicologist, 8:56. 17. Barnett, J., L. Soderberg and J. Gandy. 1988. Immunotoxic effects of propanil: dose response studies. FASEB Journ. 2(4):A914. 18. Smith, M.A., J. Gandy, S.M. Roberts, R.C. James and R.D. Harbison. 1989. Phentolamine antagonism of iodobenzene hepatotoxicity in B6C3F1 mice. The Toxicologist, 9(1):60. 19. Bates, H.K., R.D. Harbison and J. Gandy. 1989. Potentiation of ethyl methanesulfonate dominant lethality by phorone depletion of glutathione. The Toxicologist, 9(1):91. 20. Buehler, L.A., R.D. Harbison and J. Gandy. 1989. The enhancement of glutathione and its protective role against germ cell mutations. The Toxicologist, 9(1):91. 21. Barfield, L., J.B. Barnet, J. Gandy, D. Lattin and R.D. Harbison. 1989. Distributional differences of 3,3',4,4'-tetrachlorobiphenyl in BALB/c and DBA mice. FASAB Journ., 3(4):A1038. 22. Blaylock, B.L., L.S.F. Soderberg, J. Gandy, J.H. Menna and J.B. Barnett. 1989. The effect of pre/postnatal exposure to chlordane on the body weight and lymphocyte activity of BALB/c mice. FASAB Journ. 3(3):A603. 23. Gandy, J., H.K. Bates, L.A. Buehler and R.D. Harbison. 1989. Effects of reproductive tract glutathione depletion and enhancement on ethyl methanesulfonate-induced dominant lethal mutations. Internat. Congress Toxicol.: 150. 24. Durham, S.K., M.J.J. Gijels, J. Gandy and T. Imamura. 1989. Comparative long- term morphologic and biochemical changes induced by O,O,S-trimethyl phosphorothioate in the rat and mouse lung. Internat. Congress Toxicol.:91. 25. Seng, S.E., J.E. Leakey, M.P. Arlotto and J. Gandy. 1990. Age -dependent activity of testosterone 7 -hydroxylation in isolated Leydig cells of testes from Sprague- Dawley rats. The Toxicologist 10:124 26. Blaylock, B.L., J.B. Barnett, L.S.F. Soderberg, J.H. Menna and J. Gandy. 1990. The effects of prenatal exposure to chlordane on the anti -influenza immune response in BALB/c mice. The Toxicologist 10:290. 12 06/22/20 Dr. Gandy Curriculm vitae 27. Gandy, J., T. Primiano, J.L. York and R.F. Novak. 1991. Differential expression of class and glutathione s-transferases in compartments of the testis. The FASEB Journal, 5(6):A1570. 28. Frame, L.T. and J. Gandy. 1991. Glutathione localization in sertoli-germ cell cocultures. The Toxicologist, 11:248. 29. York, J.L., T. Primiano, J. Gandy, and R.F. Novak. 1992. Comparison of glutathione s-transferase expression in rat and rabbit testicular cytosol. The Toxicologist, 12:169. 30. Gandy, J., S.K. Durham, K.L. Nevels and J.L. York. 1992. The effects of testicular GSH levels and the role of glutathione transferases in DBCP-induced reproductive toxicity. The Toxicologist, 12:395. 31. Theus, S.A., L.S.F. Soderberg, J. Gandy, and J.B. Barnett. 1992. Propanil exposure alters IL-2 production. The Toxicologist, 12:50. 32. Seng, J.E., J. Gandy, R.W. Hart and J.E.A. Leakey. 1993. Localization and regulation of testicular cytochrome P450 isoforms in rats. The Toxicologist, 13:92. 33. Barnett, J., W. Zhao, L. Soderberg and J. Gandy. 1993. Propanil immunotoxicity on T cell interferon- and IL-6 production. The Toxicologist, 13:325. 34. Primiano, T., J. Gandy, J.L. York and R.F. Novak. 1993. Induction of rat hepatic cytosolic glutathione S-transferase expression following treatment with isosafrole. The Toxicologist, 13:330. 35. York, J.L., T. Primiano, J. Gandy and R.F. Novak. 1993. Glutathione S-transferase expression in rat hepatic cytosol following treatment with pyrrole. The Toxicologist, 13:330. 36. Blyer, G., K. Landreth, S. Theus, L. Soderberg, J. Gandy and J. Barnett. 1993. Propanil immunotoxicity on bone marrow stem cells. The Toxicologist, 13:422. 37. Seng, J.E., J. Gandy, M. Manjgaladze, R.W. Hart and J.E.A. Leakey. 1994. Effects of caloric restriction on cytochrome P450-dependent monooxygenase activities in rat testes. Presented at: Dietary Restriction -Implications for the Design and Interpretation of Toxicity and Carcinogenicity Studies. Washington, D.C. 38. Gandy, J., J.E. Seng, J.L. York, T. Primiano and J.E.A. Leakey. 1994. Isosafrole alters cytochrome P450 IA activity and glutathione S-transferase expression in the rat testis. The Toxicologist, 14:86. 39. Barnett, J., K. Landreth, T. Lillis, R. Schafer and J. Gandy. 1994. Effects of propanil on splenic hemopoiesis. The Toxicologist, 14:396. 40. Gandy, J., S.K. Durham and T. Imamura. 1994. Cellular and biochemical mechanisms of lung injury induced by trial kylphosphorothioates. Union des Societes Suisses de Biologie Experimentale, Berne, Switzerland. 13 06/22/20 Dr. Gandy Curriculm vitae 41. Manjgaladze, M., N. Kozlovskaya, J.E. Seng, J.E.A. Leakey and J. Gandy. 1994. Effects of inducers and inhibitors of cytochrome P450 (CYP 1A1) on microsomal 7- ethoxy- and 7-benzoxyresorufin metabolism in various rat tissues. ISSX Proceedings, 6:203. 42. Seng, J.E., J. Gandy, O. Awad, R. Lipman, R.T. Bronson, R.W. Hart and J.E.Leakey. 1995. Effects of dietary restriction on expression of testicular cytochrome P450isoforms associated with the metabolic activation of carcinogens. ISSX Proceedings, 8:333. 43. Ronis, M.J.J., T.M. Badger, J. Gandy, L.M. Bell and K. Green. 1995. Anti - androgenic effects of perinatal cypermethrin exposure in the developing rat. Internatl. Congress Toxicol.- VII. 44. Gandy, J., J.E. Seng, V.M. Baker, O. Awad, R.W. Hart and J.E. Leakey. 1996. Flutamide-induced rat testicular tumors and lypoxygenase activities are reduced by caloric restriction. Fund. Appl. Toxicol., Suppliment, 30:122. 45. Gandy, J., S.M. Richards, J.D. Mattice and T.L. Lavy. 1996. Airborne concentrations of propanil within residences of families living adjacent to aerially sprayed rice fields. Am. Industrial Hygiene Conf. 46. McClure, G.Y.H., R.M. Helm, A.W. Burks and J. Gandy. 1996. Evaluation of the immunotoxic properties of the herbicide, propanil, in farm families. Am. Industrial Hygiene Conf. 47. McClure, G.Y.H., R.M. Helm, K. Stine, A.W. Burks, S.M. Jones, and J. Gandy. 1997. Evaluation of immune parameters in propanil exposed farm families. Fund. Appl. Toxicol., Suppliment, 36:264. 48. Chang, C.-W., J. Seng, J.E. Leakey, R.W. Hart, and J. Gandy. 1997. Diet -induced changes in testicular toxicity of flutamide are mediated via altered LH and hydroxyflutamide levels. Fund. Appl. Toxicol., Suppliment, 36:356. 49. Gandy, J., S.W. Williams, R. Hill, and P.T. Goad. 1999. Determination of acceptable exposure limits for the anti -viral agent ribavirin. Toxicological Sci, Supplement, 48:80. 50. Gandy, J. and A.J. Harris. 2005. Health effects reported in Texas homes with visible mold and/or water damage. The Toxicologist 84:86. 51. Nony, P., D.W. Gaylor, G.C. Millner, A.C. Nye, and J. Gandy. 2008. Residual PAHs, PCBs, PCDDs, and PCDFs in soil and house dust following an industrial chemical release and fire. 2008 Itinerary Planner No. 801. Society of Toxicology. 52. Gandy, J. and Cranmer, M.F. 2014. University of Arkansas for Medical Sciences (UAMS) Regulatory Sciences Training and Research Program - A partnership between UAMS and NCTR. Montreal, Canada. 53. Gandy, J. and Cranmer, M.F., Harril, A. 2015. University of Arkansas for Medical Sciences (UAMS) Regulatory Sciences Training and Research Program - A partnership between UAMS and NCTR. Parma, Italy. 14 06/22/20 Dr. Gandy Curriculm vitae 54. Gandy, J. 2017. University of Arkansas for Medical Sciences (UAMS) Regulatory Sciences Training and Research Program — A partnership between UAMS and NCTR. Global Summit on Regulatory Sciences, Brasilia, Brazil. is 06/22/20 HUDA SHARAF, M.D. BOARD CERTIFIED INTERNAL MEDICINE 2525 North Fennchurch Way ♦ Fayetteville, Arkansas ♦ (479) 200-7517 ♦ hudamai@aol.com EDUCATION & LICENSES WASHINGTON UNIVERSITY SCHOOL OF MEDICINE — ST. LOUIS, MISSOURI .TUNE 2000 Residency, BARNES-JEWISH HOSPITAL Internal Medicine/Categorical Track ♦ Twin Studies Lecture for Internal Medicine Grand Rounds ♦ CHF research study with Dr. Joe Rogers WASHINGTON UNIVERSITY SCHOOL OF MEDICINE — ST. LOUIS, MISSOURI JUNE 1998 Internship, BARNES-JEWISH HOSPITAL Internal Medicine/Categorical Track UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES — LITTLE ROCK, ARKANSAS MAY 1997 Doctor of Medicine, 3.60 GPA, Rank 13/123 ♦ Alpha Omega Alpha Honor Society UNIVERSITY OF ARKANSAS — FAYETTEVILLE, ARKANSAS MAY 1993 Bachelor of Science in Chemistry, 3.68 GPA ♦ Cum Laude LICENSED PHYSICIAN — State of Arkansas PROFESSIONAL EXPERIENCE MEDICAL DIRECTOR/STAFF PHYSICIAN — FAYETTEVILLE, ARKANSAS University of Arkansas JANUARY 2008 — PRESENT Primary care physician for The Pat Walker Health Center which provides healthcare for the University community to include students, faculty and staff. Serve as physician collaborator for an APRN. Served as Medical Director from September 2010 through August 2012 and assumed the permanent position in February 2013. STAFF PHYSICIAN — ST. LOUIS, MISSOURI OCTOBER 2003 — NOVEMBER 2007 Washington University Primary care physician for Washington University Student Health Center which provides healthcare for 11,000 students. Served as physician collaborator for a PA and an APN. CLINICAL INSTRUCTOR — ST. LOUIS, MISSOURI AUGUST 2001— OCTOBER 2003 Emergency Medicine Division, Washington University School of Medicine Staffed ER patient cases with APNs, PAs and residents. Served as the physician collaborator for an APN. CLINICAL ASSISTANT PROFESSOR — GAINESVILLE, FLORIDA AUGUST 2000 —.TUNE 2001 Internal Medicine Division, University of Florida Primary care physician for outpatient and inpatient care for a 300 bed hospital. Rotated call with hospitalist group with responsibilities to include patient admission, ICU management, pre -op clearance and carried CODE beeper. ♦ Voluntarily mentored and trained medical students as a Physical Diagnosis Course Instructor. CERTIFICATIONS & MEMBERSHIPS Board Certified in Internal Medicine BLS ACP Member HOBBIES & INTERESTS Spending Time with Family ♦ Reading ♦ Traveling Gary Berner M.D. Chief Medical Officer at Community Clinic gbemer@communityclinicnwa.org RESIDENCY/INTERNSHIP 7/12- 6/16 UAMS; Little Rock, AR Internal Medicine & Pediatrics EDUCATION 8/08- 5/12 UAMS- College of Medicine; Little Rock, Arkansas Doctor of Medicine 8/03- 5/07 Hendrix College; Conway, AR Bachelor of Arts in Biology 8/01- 5/03 Russellville High School; Russellville, AR EMPLOYMENT 8/16- Present Community Clinic of Northwest Arkansas Began practicing in General Internal Medicine & Pediatrics at the location in Fayetteville. In January 2019 I took over the role as Chief Medical Officer. I give advice to the administrative team on best medical practices, preventative care, de- velop new programing (including Pre -Exposure Prophylaxis for HIV, Medication As- sisted Treatment for Opioid Addiction, Hepatitis C Treatment Program, and others), liai- son to local health partners (ACNW, UAMS, Childrens Safety Center, etc.), oversee UAMS Resident and Medical Student Education, collaborating physician to our nurse practitioners, manage recruiting and staffing of medical providers, and consultant to phy- sicians and NPs on complex medical cases. I oversaw the development and implementa- tion of Community Clinics robust response to the COVID 19 Pandemic. 7/07- 7/08 Hendrix College; Conway, AR Research Assistant- My responsibilities began by running the ex- periments, collecting data, and analyzing the results. Additionally I monitored the needs and supplies for the lab. By 10/07, my role transitioned to teaching and supervising un- dergraduate researchers to do the same. HONORS AND AWARDS 5/16 UAMS Pediatric Critical Care Resident of the Year. Winner 3/16 UAMS Resident of the Year. Runner Up 7/15- 6/16 Chief Resident. Internal Medicine & Pediatrics. 3/15- 6/16 Chairmen's Scholar. Arkansas Children's Hospital '08-` 12 Arkansas Rural Medicine Practice Scholarship. UAMS. 2003- 2007 Hendrix College Soccer. 4 years Varsity, All -Conference '04 & '06, Academic All -Conference '03- '07, Captain `06 PROFESSIONAL ORGANIZATIONS 8/08- present AAP LICENSURE S/CERTIFICATIONS Arkansas Medical License Board Certified Pediatrician Board Eligible Internal Medicine Physician BLS, PALS Certified EXTRACURRICULAR ACTIVITIES 7/09- 8/09 Medical Mission Trip. Lilongwe, Malawi. Current Member of St. Pauls Episcopal Church. Fayetteville, AR Current Hendrix College Alumni Board. Conway, AR RESEARCH & PUBLICATIONS Resarch Proiects 7/07- 8/08 Interactions of Histone Protein Complex with DNA Genetics Department- Andrea Duina (PI) Hendrix College- Conway, AR Project: The goal in our lab was to gain insights into the process of eukaryotic gene transcription. Playing particular interest to the interactions that occur between the histone chaperone complex and chromatin during transcription. 2 Publications Myers CN, Berner GB, Duina A, et all. Mutant Versions of the S. cerevisiae Transcrip- tion Elongation Factor Spt16 Define Regions of Spt16 That Functionally Interact with Histone H3. PLoS One. 2011; 6(6): e20847. PERSONAL 7/2/11- Present. Happily married to Ryan Hughes Berner- RN at Arkansas Children's Northwest. Father to Ruby and Hazel. Interests- Cooking and canoeing with my wife. Hiking with the family and our dog. Watching and playing soccer when free time allows. Dabbling in woodworking, fly fish- ing, and music. Joey Gardner, DSW, LCSW 4055 W. Song Bird PI Fayetteville, AR 72704 JoeyJGardner@gmail.com 870-692-1440 CURRICULUM VITAE EDUCATION DSW Walden University; School of Social Work 2018 Doctoral Program; Minneapolis, Minnesota Dissertation: "Understanding Social Workers' Knowledge of Foster Care Drift"; Administrative Concentration MS Walden University; Information Technology Minneapolis, Minnesota; Health Informatics Concentration 2019-Present MSW University of Southern California; School of Social Work- 2013 Los Angeles California; Mental Health Concentration BA University of Arkansas; Fayetteville, Arkansas; 2012 Sociology and Criminal ACADEMIC RESEARCH EXPERIENCE Dissertation: Understanding Social Workers' Knowledge of Foster Care Drift (Fall 2018) CONTRIBUTIONS TO THE UNIVERSITY AND COMMUNITY Instructor Adjunct Instructor-UAPTC, 2019-present Advising Academic Advisor UoA —Autism Support Program, 2012- 2015 Academic Advisor UoA- Freshman Engineering Program, 2010 Other Contributions Center of Training Transportation Professional -Proctor UoA, 2009 National Cares Mentoring Movement- Board Member Pine Bluff, AR 2013-present Martin Luther King Planning Committee -Board Member, 2011-2013 SPECIAL AWARDS National Honor Society, Criminal Justice- UoA Selected for inclusion in Who's Who in American Universities and Colleges- UoA National Honor Society, Social Work -University of Southern California PROFESSIONAL AFFILIATIONS National Association of Social Workers (Arkansas Chapter) — 2016-present Kappa Alpha Psi, Fraternity Inc. Fayetteville Alumni Chapter National Cares Board Member (Pine Bluff, AR) ICVR, King Team Board Member (Pine Bluff, AR) SOCIAL WORK PRACTICE EXPERIENCE 3/20-5/20: Vantage Point. Fayetteville, Arkansas. Director of Admissions Supports team in facilitating incoming inquiries of prospective clients, loved ones and mental health/medical professionals with a sense of urgency and compassion. Exhibits a high level of professionalism and excellent customer service skills with each call, tour and admission. Obtains clinical information and other medical information to determine appropriateness for TK. Assist callers in identifying the benefits of TK program as relevant to their individual situation. Utilizes an Intervention style approach (when applicable) to assist callers in working through ambivalence. Prepares and facilitates all aspects of the admissions process, including all intake paperwork. Maintains Salesforce database by entering incoming and outgoing calls 5/18-2/20, 5/20-Present: Beacon Health Options. Little Rock, AR. Supervisor, Care Coordinator Supervisor Oversee day-to-day operations within the Clinical Department for functions handled by non -licensed clinical staff; Ensures assigned staff complete all requirements of the program as outlined by Arkansas Medicaid, Ensure process and procedures are followed consistently, and the program operations run seamlessly; Responsible for training, meetings, scheduling, monitoring productivity, and overall management of assigned staff; Responsible for identifying operational issues which could impact clients and members; Participate in strategic, systems, and organizational planning of department and the company as a whole. 12/16-5/18: Beacon Health Options. Little Rock, Arkansas. Care Manager. Maintain confidentiality, ethical professional standards, adhering to clinical policy and procedures and benefit plan requirements; Utilize rounds and case consults with clinical supervisor, peer advisor for cases outside criteria or not processing; Review and process prior authorizations for inpatient and outpatient services; Care coordination/Reintegration management. 5/15-12/16: Vantage Point of Northwest Arkansas. Fayetteville Arkansas. Intake Coordinator. Cultivated strong business relationships to drive organization development; Ensured organization is prepared for internal audits through analysis/preparation of medical records; Administered financial processes including verifying and precertification of third party insurances; Process admissions forms required by regulating agencies; Interview clients, review records, conduct assessments, or confer with other professionals to evaluate the mental or physical condition of clients or patients; Collaborate with counselors, physicians, or nurses to plan or coordinate treatment, drawing on social work experience and patient needs.; Refer patient, client, or family to community resources for housing or treatment to assist in recovery from mental or physical illness, following through to ensure service efficacy. 1/14-5/15: Ozark Guidance. Fayetteville, Arkansas. Mental Health Professional Conduct psychosocial assessments and master treatment plans; Treatment team staff meetings with site director and treatment team; Fill out and maintain client -related paperwork, including federal and state mandated forms; client diagnostic records, and progress notes; case management 4/13-11/13: CREOKS Behavioral Health Services. Stilwell, Oklahoma. Behavioral Health Rehabilitation Specialist Responsible for teaching rehabilitative skills necessary for performing activities of daily; Conducts psychosocial assessments and master treatment plans for clients; Parenting, substance abuse, and adult education groups 8/12-5/15: Autism Support Program, University of Arkansas, Fayetteville, Arkansas. Academic Coach. Provides support to students with high functioning autism, Asperger's Syndrome, PDD-NOS, and non-verbal learning disabilities; Assisted students in developing in three critical areas: academic, the transition to independent adult roles, and proper use of social skills. 5/11-8/11: Department of Community Corrections- Fayetteville, Arkansas. Intern. Compiled information regarding clients' progress in society; Set-up employment searchers for clients; organized and maintained documents; prepared social histories. HERSHEL H. GARNER, JD,MD Highlands Oncology Group Curriculum Vitae PERSONAL DATA Date of Birth: 07/19/1953 Place of Birth: Little Rock, Arkansas Citizenship: USA Marital Status: Married Home Address: 3390 E. Mission Boulevard Fayetteville, AR 72704 EMPLOYMENT Highlands Oncology Group, 06/02/2008 — Present Correspondence Address My Service Address My Service Address 3232 N. North Hills Blvd. 808 South 52nd Street 60 E. Monte Painter Dr. Fayetteville, AR 72703 Rogers, AR 72758 Fayetteville, AR 72703 (479) 587-1700 (479) 361-2585 (479) 361-2585 FAX: (479)587-1366 FAX: (479) 587-1366 FAX: (479) 571-1986 Northwest Arkansas Radiation Oncology Associates, for Northwest Arkansas Radiation Therapy Institute (NARTI), 07/01/1990 — 06/01/08 PO Box 1955 Springdale, AR 72762 (479) 361-5847 FAX: (479) 361-9104 EDUCATION College B.B.A. — Baylor University Waco, TX 1975 Law School J.D. — University of Arkansas Little Rock, AR 1980 Medical School M.D. — University of Arkansas College of Medicine Little Rock, AR 08/01 /1981 — 05/17/1986 Hershel H. Garner, MD Curriculum Vitae Page 2 Internship University of Arkansas for Medical Sciences Little Rock, AR Specialty: Transitional 07/01 /1986 — 06/30/1987 Residency University of Louisville Program Louisville, KY Specialty: Radiation Oncology 07/01 /1987 — 06/30/1991 BOARD CERTIFICATIONS Radiation Oncology -American Board of Radiology Certification Date: 06/09/1994 LICENSURE Arkansas, C-7086 Original Issue Date, 08/08/1986 — current PROFESSIONAL ASSOCIATIONS American Medical Association Arkansas Medical Society American Society for Therapeutic Radiology and Oncology Washington County Medical Society American College of Radiology American College of Radiation Oncology MEDICAL POSITIONS HELD Ethics Committee Chairman, Washington Regional Medical Center Ethics Committee Chairman, Northwest Medical Center Circle of Life Hospice IRB Chairman, Northwest Medical Center Cancer Committee, Northwest Medical Center Cancer Committee, Washington Regional Medical Center Clinical Assistant Professor, University of Arkansas for Medical Sciences State of Arkansas BreastCare Advisory Board Chair Department of Radiation Oncology, UAMS